Allergy and allergic diseases. First of two parts.

[1]  Braun,et al.  The role of neurotrophins in allergic bronchial asthma , 2000, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[2]  P. Holt,et al.  A Polymorphism* in the 5' flanking region of the CD14 gene is associated with circulating soluble CD14 levels and with total serum immunoglobulin E. , 1999, American journal of respiratory cell and molecular biology.

[3]  P. Rogers,et al.  Peptide dose, affinity, and time of differentiation can contribute to the Th1/Th2 cytokine balance. , 1999, Journal of immunology.

[4]  R. Naclerio,et al.  Nasal challenge with ragweed pollen in hay fever patients. Effect of immunotherapy. , 1985, The Journal of clinical investigation.

[5]  K. Hoffmann‐Sommergruber,et al.  Four recombinant isoforms of Cor a I, the major allergen of hazel pollen, show different IgE-binding properties. , 1993, European journal of biochemistry.

[6]  A. Togias,et al.  Down-regulation of Fc(epsilon)RI expression on human basophils during in vivo treatment of atopic patients with anti-IgE antibody. , 1997, Journal of immunology.

[7]  P. Askenase,et al.  C-C chemokines in allergen-induced late-phase cutaneous responses in atopic subjects: association of eotaxin with early 6-hour eosinophils, and of eotaxin-2 and monocyte chemoattractant protein-4 with the later 24-hour tissue eosinophilia, and relationship to basophils and other C-C chemokines (mono , 1999, Journal of immunology.

[8]  F. Levi-Schaffer,et al.  Blood eosinophils from atopic donors express messenger RNA for the α, β, and γ subunits of the high-affinity IgE receptor (FcϵRI) and intracellular, but not cell surface, α subunit protein , 2000 .

[9]  J. Castro‐Rodriguez,et al.  Siblings, day-care attendance, and the risk of asthma and wheezing during childhood. , 2000, The New England journal of medicine.

[10]  J. Vandekerckhove,et al.  Interleukin 5 regulates the isoform expression of its own receptor alpha-subunit. , 2000, Blood.

[11]  S. Durham,et al.  The immunopathology of extrinsic (atopic) and intrinsic (non-atopic) asthma: more similarities than differences. , 1999, Immunology today.

[12]  F. Hargreave,et al.  Late cutaneous allergic responses in isolated IgE-dependent reactions. , 1973, The Journal of allergy and clinical immunology.

[13]  K. Arndt,et al.  Recent therapeutic advances in dermatology. , 2000, JAMA.

[14]  S. Durham,et al.  Messenger RNA expression of the cytokine gene cluster, interleukin 3 (IL-3), IL-4, IL-5, and granulocyte/macrophage colony-stimulating factor, in allergen-induced late-phase cutaneous reactions in atopic subjects , 1991, The Journal of experimental medicine.

[15]  S. Durham,et al.  IL‐13 production by allergen‐stimulated T cells is increased in allergic disease and associated with IL‐5 but not IFN‐γ expression , 1997, Immunology.

[16]  D. Meyers,et al.  HLA-Dw2: a genetic marker for human immune response to short ragweed pollen allergen Ra5. I. Response resulting primarily from natural antigenic exposure , 1982, The Journal of experimental medicine.

[17]  Dominique Charron,et al.  HLA-DR Restricted Peptide Candidates for Bee Venom Immunotherapy , 2000, The Journal of Immunology.

[18]  K. B. Hafner,et al.  Treatment of cat allergy with T-cell reactive peptides. , 1996, American journal of respiratory and critical care medicine.

[19]  P. Naaber,et al.  Intestinal microflora of Estonian and Swedish infants , 1997, Acta paediatrica.

[20]  R. Bush,et al.  Treatment of allergic asthma with monoclonal anti-IgE antibody. rhuMAb-E25 Study Group. , 1999, The New England journal of medicine.

[21]  I. Strickland,et al.  Double-blind controlled trial of effect of housedust-mite allergen avoidance on atopic dermatitis , 1996, The Lancet.

[22]  E. Israel,et al.  Correction: Treatment of Asthma with Drugs Modifying the Leukotriene Pathway. , 1999, The New England journal of medicine.

[23]  G. Rook,et al.  Give us this day our daily germs. , 1998, Biologist.

[24]  P. Sly,et al.  Transplacental priming of the human immune system to environmental allergens: universal skewing of initial T cell responses toward the Th2 cytokine profile. , 1998, Journal of immunology.

[25]  L. Borish,et al.  Interleukin-4 receptor in moderate atopic asthma. A phase I/II randomized, placebo-controlled trial. , 1999, American journal of respiratory and critical care medicine.

[26]  A. Nagler,et al.  Human Eosinophils Regulate Human Lung- and Skin-Derived Fibroblast Properties in vitro: A Role for Transforming Growth Factor β (TGF-β) , 1999 .

[27]  S. Constant,et al.  Induction of Th1 and Th2 CD4+ T cell responses: the alternative approaches. , 1997, Annual review of immunology.

[28]  D D Donaldson,et al.  Interleukin-13: central mediator of allergic asthma , 1998 .

[29]  Gaga,et al.  Grass pollen immunotherapy decreases the number of mast cells in the skin , 1999, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[30]  S. Durham,et al.  Immunologic changes associated with allergen immunotherapy. , 1998, The Journal of allergy and clinical immunology.

[31]  C. Bruijnzeel-Koomen,et al.  A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis. , 1998, Immunology today.

[32]  R. Kastelein,et al.  IGIF Does Not Drive Th1 Development but Synergizes with IL-12 for Interferon-γ Production and Activates IRAK and NFκB , 1997 .

[33]  S. Durham,et al.  Cytokine messenger RNA expression for IL-3, IL-4, IL-5, and granulocyte/macrophage-colony-stimulating factor in the nasal mucosa after local allergen provocation: relationship to tissue eosinophilia. , 1992, Journal of immunology.

[34]  J. Denburg.  Hemopoietic progenitors and cytokines in allergic inflammation , 1998, Allergy.

[35]  R. Dockhorn,et al.  Use of an anti-IgE humanized monoclonal antibody in ragweed-induced allergic rhinitis. , 1997, The Journal of allergy and clinical immunology.

[36]  P. Naaber,et al.  The intestinal microflora in allergic Estonian and Swedish 2‐year‐old children , 1999, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[37]  S. Holgate.  The epidemic of allergy and asthma , 1999, Nature.

[38]  Ennis,et al.  Sensory neuropeptides induce histamine release from bronchoalveolar lavage cells in both nonasthmatic coughers and cough variant asthmatics , 2000, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[39]  Christian Fritzsch,et al.  Increasing prevalence of hay fever and atopy among children in Leipzig, East Germany , 1998, The Lancet.

[40]  J. Kinet,et al.  The high-affinity IgE receptor (Fc epsilon RI): from physiology to pathology. , 1999 .

[41]  S. Durham,et al.  Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late-phase cutaneous responses. , 1993, The Journal of clinical investigation.

[42]  D. Malone,et al.  A national estimate of the economic costs of asthma. , 1997, American journal of respiratory and critical care medicine.

[43]  G. Stingl,et al.  IgE-mediated allergen presentation via Fc epsilon RI on antigen-presenting cells. , 1997, International archives of allergy and immunology.

[44]  R. Helm,et al.  Identification and mutational analysis of the immunodominant IgE binding epitopes of the major peanut allergen Ara h 2. , 1997, Archives of biochemistry and biophysics.

[45]  C. Mackay,et al.  Chemokine receptor usage by human eosinophils. The importance of CCR3 demonstrated using an antagonistic monoclonal antibody. , 1997, The Journal of clinical investigation.

[46]  T. Nicolai,et al.  Prevalence of asthma and atopy in two areas of West and East Germany. , 1994, American journal of respiratory and critical care medicine.

[47]  P. Openshaw,et al.  Protective and harmful effects of viral infections in childhood on wheezing disorders and asthma. , 2000, American journal of respiratory and critical care medicine.

[48]  M. Chapman,et al.  Risk factors for asthma in inner city children. , 1992, The Journal of pediatrics.

[49]  G. Gleich,et al.  Ovalbumin Sensitization Changes the Inflammatory Response to Subsequent Parainfluenza Infection , 1999, The Journal of experimental medicine.

[50]  Krishnendu Roy,et al.  Oral gene delivery with chitosan–DNA nanoparticles generates immunologic protection in a murine model of peanut allergy , 1999, Nature Medicine.

[51]  W. Cookson,et al.  The alliance of genes and environment in asthma and allergy , 1999, Nature.

[52]  D. Kemeny,et al.  The subclass of IgG antibody in allergic disease: II. The IgG subclass of antibodies produced following natural exposure to dust mite and grass pollen in atopic and non‐atopic individuals , 1989, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[53]  J. Kochan,et al.  Autoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticaria. , 1993, The New England journal of medicine.

[54]  J. D. Neely,et al.  Linkage analysis of IL4 and other chromosome 5q31.1 markers and total serum immunoglobulin E concentrations. , 1994, Science.

[55]  Nicholas Schork,et al.  Pharmacogenetic association between ALOX5 promoter genotype and the response to anti-asthma treatment , 1999, Nature Genetics.

[56]  P. Seed,et al.  Chronic idiopathic urticaria: comparison of the clinical features of patients with and without anti-FcepsilonRI or anti-IgE autoantibodies. , 1999, Journal of the American Academy of Dermatology.

[57]  N. Åberg,et al.  Increase of asthma, allergic rhinitis and eczema in Swedish schoolchildren between 1979 and 1991 , 1995, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[58]  B. Haselden,et al.  Immunoglobulin E–independent Major Histocompatibility Complex–restricted T Cell Peptide Epitope–induced Late Asthmatic Reactions , 1999, The Journal of experimental medicine.

[59]  E. Paoletti,et al.  Comparison of numerous delivery systems for the induction of cytotoxic T lymphocytes by immunization , 1996, European journal of immunology.

[60]  S. Rankin,et al.  Mechanisms of Acute Eosinophil Mobilization from the Bone Marrow Stimulated by Interleukin 5: The Role of Specific Adhesion Molecules and Phosphatidylinositol 3-Kinase , 1998, The Journal of experimental medicine.

[61]  B. Heyman,et al.  CD23/IgE-mediated regulation of the specific antibody response in vivo. , 1994, Journal of immunology.

[62]  F. Finkelman,et al.  Antigen presentation is enhanced by targeting antigen to the Fc epsilon RII by antigen-anti-Fc epsilon RII conjugates. , 1994, Journal of immunology.

[63]  L. Borish,et al.  IL-10: evolving concepts. , 1998, The Journal of allergy and clinical immunology.

[64]  M. Humbert,et al.  Basophils, eosinophils, and mast cells in atopic and nonatopic asthma and in late-phase allergic reactions in the lung and skin. , 2000, The Journal of allergy and clinical immunology.

[65]  H. Okamura,et al.  LPS-Stimulated SJL Macrophages Produce IL-12 and IL-18 That Inhibit IgE Production In Vitro by Induction of IFN-γ Production from CD3intIL-2Rβ+ T Cells , 1998, The Journal of Immunology.

[66]  W. Cookson,et al.  A new variant of the beta subunit of the high-affinity receptor for immunoglobulin E (Fc epsilon RI-beta E237G): associations with measures of atopy and bronchial hyper-responsiveness. , 1996, Human molecular genetics.

[67]  K. Hoffmann‐Sommergruber,et al.  Dissection of immunoglobulin E and T lymphocyte reactivity of isoforms of the major birch pollen allergen Bet v 1: potential use of hypoallergenic isoforms for immunotherapy , 1996, The Journal of experimental medicine.

[68]  D. Dockery,et al.  Predictors of asthma and persistent wheeze in a national sample of children in the United States. Association with social class, perinatal events, and race. , 1990, The American review of respiratory disease.

[69]  S. Romagnani.  Human TH1 and TH2 subsets: doubt no more. , 1991, Immunology today.

[70]  S. Bonini,et al.  Nerve Growth Factor: An Important Molecule in Allergic Inflammation and Tissue Remodelling , 1999, International Archives of Allergy and Immunology.

[71]  B. Haselden,et al.  Costimulation through CD86 is involved in airway antigen-presenting cell and T cell responses to allergen in atopic asthmatics. , 1998, Journal of immunology.

[72]  C. Akdis,et al.  Role of interleukin 10 in specific immunotherapy. , 1998, The Journal of clinical investigation.

[73]  R. Barlow,et al.  Plasmapheresis for severe, unremitting, chronic urticaria , 1992, The Lancet.

[74]  J. Wallace,et al.  Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism , 2000, Nature Medicine.

[75]  N. Najafian,et al.  Nonallergic individuals recognize the same T cell epitopes of Bet v 1, the major birch pollen allergen, as atopic patients. , 1995, Journal of immunology.

[76]  R. Egan,et al.  Effects of an antibody to interleukin-5 in a monkey model of asthma. , 1995, American journal of respiratory and critical care medicine.

[77]  B. Wüthrich,et al.  Prevalence of hay fever and allergic sensitization in farmer's children and their peers living in the same rural community , 1999, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[78]  W. Cookson,et al.  Tumour necrosis factor haplotypes and asthma. , 1997, Human molecular genetics.

[79]  S. Durham,et al.  Activation of CD4+ T cells, increased TH2-type cytokine mRNA expression, and eosinophil recruitment in bronchoalveolar lavage after allergen inhalation challenge in patients with atopic asthma. , 1993, The Journal of allergy and clinical immunology.

[80]  T. Rafnar,et al.  Molecular identification of an IgE-dependent histamine-releasing factor. , 1995, Science.

[81]  D. Corry,et al.  Induction and regulation of the IgE response , 1999, Nature.

[82]  E. Raz,et al.  Gene vaccination: plasmid DNA is more than just a blueprint. , 1998, Immunology today.

[83]  S. Durham,et al.  Allergen immunotherapy: does it work and, if so, how and for how long? , 2000, Thorax.

[84]  J. Ryan.  Interleukin-4 and its receptor: essential mediators of the allergic response. , 1997, The Journal of allergy and clinical immunology.

[85]  H. Boushey,et al.  The effect of an anti-IgE monoclonal antibody on the early- and late-phase responses to allergen inhalation in asthmatic subjects. , 1997, American journal of respiratory and critical care medicine.

[86]  S. Durham,et al.  Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. , 1992, The New England journal of medicine.

[87]  P. Sly,et al.  The role of allergy in the development of asthma , 1999, Nature.